Display options
Share it on

J Adv Pharm Technol Res. 2016 Apr-Jun;7(2):32-6. doi: 10.4103/2231-4040.177201.

Characterization of Yuhushiella sp. TD-032 from the Thar Desert and its antimicrobial activity.

Journal of advanced pharmaceutical technology & research

A Ibeyaima, Jyoti Rana, Anuj Dwivedi, Sanjay Gupta, Sanjeev K Sharma, Narendra Saini, Indira P Sarethy

Affiliations

  1. Department of Biotechnology, Jaypee Institute of Information Technology, Noida, India.
  2. Department of Microbiology, Pushpanjali Crosslay Hospital, Ghaziabad, Uttar Pradesh, India.

PMID: 27144149 PMCID: PMC4850765 DOI: 10.4103/2231-4040.177201

Abstract

During a screening program for antimicrobial compounds from underexplored habitats, a Gram-positive bacterium TD-032, was isolated from arid soil, Thar Desert (India), and analyzed for its morphological, physicochemical, and antimicrobial properties. The 16S ribosomal DNA (rDNA) sequence of the isolate was further studied for the novelty of γ-hyper variable region. TD-032 was grown in large-scale culture, and aqueous and organic solvent extracts analyzed for antimicrobial activity. Culture characteristics showed a lack of diffusible and melanoid pigments. The morphological features were pale yellow aerial mycelium colony color with brownish yellow substrate mycelium and leathery texture. The isolate could grow at 1% concentration of sodium chloride, temperature of 40°C, and a wide range of pH (7.0-12.0). An evaluation for extracellular enzymatic activities showed secretion of gelatinase(s), cellulase(s), and lipase(s). The γ-hyper variable region of 16S rDNA sequence of TD-032 showed 98.33% relatedness to Yuhushiella deserti, indicating a potential new species. Aqueous and ethyl acetate extracts showed antimicrobial activity against Gram-positive and Gram-negative bacteria inclusive clinical isolates. Inhibition of both test bacteria suggests that TD-032 produces a broad spectrum of antimicrobial substances.

Keywords: Actinomycetes; Thar Desert; antimicrobial activity; hyper-variable regions/16S ribosomal DNA

References

  1. Appl Environ Microbiol. 2004 Mar;70(3):1787-94 - PubMed
  2. J Appl Microbiol. 2015 Jun;118(6):1306-14 - PubMed
  3. FEMS Microbiol Lett. 1997 Jun 15;151(2):249-55 - PubMed
  4. Antonie Van Leeuwenhoek. 2009 Feb;95(2):121-33 - PubMed
  5. Am J Clin Pathol. 1966 Apr;45(4):493-6 - PubMed
  6. Antonie Van Leeuwenhoek. 2014 May;105(5):849-61 - PubMed
  7. Mol Biol Evol. 2013 Dec;30(12):2725-9 - PubMed
  8. FEMS Microbiol Ecol. 2002 Nov 1;42(2):269-76 - PubMed
  9. J Bacteriol. 1948 Jul;56(1):107-14 - PubMed
  10. J Clin Microbiol. 2004 Dec;42(12):5957-60 - PubMed
  11. J Med Chem. 2008 May 8;51(9):2589-99 - PubMed
  12. J Antibiot (Tokyo). 2011 Dec;64(12):775-80 - PubMed
  13. Int J Syst Evol Microbiol. 2012 Mar;62(Pt 3):716-21 - PubMed
  14. Int J Syst Evol Microbiol. 2004 Jan;54(Pt 1):247-52 - PubMed
  15. Indian J Pharm Sci. 2009 Sep;71(5):499-504 - PubMed
  16. Can J Microbiol. 2006 Apr;52(4):373-82 - PubMed
  17. J Nat Prod. 2011 Jun 24;74(6):1491-9 - PubMed
  18. Int J Syst Evol Microbiol. 2011 Mar;61(Pt 3):621-30 - PubMed
  19. BMC Microbiol. 2013 Jun 22;13:145 - PubMed

Publication Types